1-[hexadecoxy(hydroxy)phosphoryl]oxybutyl-trimethylazanium
C23H51NO4P+ — CID 156631411
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[hexadecoxy(hydroxy)phosphoryl]oxybutyl-trimethylazanium
1-[hexadecoxy(hydroxy)phosphoryl]oxybutyl-trimethylazanium (PubChem CID 156631411) has the molecular formula C23H51NO4P+ and a molecular weight of 436.64 g/mol. Its IUPAC name is 1-[hexadecoxy(hydroxy)phosphoryl]oxybutyl-trimethylazanium.
Molecular Properties
| Compound Name | 1-[hexadecoxy(hydroxy)phosphoryl]oxybutyl-trimethylazanium |
|---|---|
| PubChem CID | 156631411 |
| Molecular Formula | C23H51NO4P+ |
| Molecular Weight | 436.64 g/mol |
| Exact Mass | 436.36 |
| IUPAC Name | 1-[hexadecoxy(hydroxy)phosphoryl]oxybutyl-trimethylazanium |
| SMILES | CCCCCCCCCCCCCCCCOP(=O)(O)OC(CCC)[N+](C)(C)C |
| InChI | InChI=1S/C23H50NO4P/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-20-22-27-29(25,26)28-23(21-7-2)24(3,4)5/h23H,6-22H2,1-5H3/p+1 |
| InChIKey | XYUHMEPFUAXOIT-UHFFFAOYSA-O |
| XLogP | 7.43 |
| TPSA | 55.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.64 |
| LogP ≤ 5 | 7.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156631411 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.